EVALUATING BIOPHARMA Trademark

Trademark Overview

On Monday, April 18, 2022, a trademark application was filed for EVALUATING BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the EVALUATING BIOPHARMA trademark a serial number of 97368815. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, October 18, 2023. This trademark is owned by BioPlan Associates, Inc.. The EVALUATING BIOPHARMA trademark is filed in the Advertising, Business and Retail Services category with the following description:

Special event planning for business purposes
evaluating biopharma

General Information

Serial Number97368815
Word MarkEVALUATING BIOPHARMA
Filing DateMonday, April 18, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, October 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesSpecial event planning for business purposes

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, April 25, 2022
Primary Code035
First Use Anywhere DateSaturday, June 5, 2021
First Use In Commerce DateSunday, August 15, 2021

Trademark Owner History

Party NameBioPlan Associates, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAnnapolis, MD 21403

Trademark Events

Event DateEvent Description
Wednesday, October 18, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, October 18, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, October 18, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, July 3, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, July 3, 2023FINAL REFUSAL E-MAILED
Monday, July 3, 2023FINAL REFUSAL WRITTEN
Thursday, April 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 10, 2023NON-FINAL ACTION E-MAILED
Friday, February 10, 2023NON-FINAL ACTION WRITTEN
Thursday, February 2, 2023ASSIGNED TO EXAMINER
Monday, April 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 21, 2022NEW APPLICATION ENTERED

Related Keywords

biopharma evaluating purposes business planning event special